Official UK procurement notice
TB Testing Services · UK public procurement notice
Authority: University Hospitals of Derby and Burton NHS Foundation Trust (Central government)
What is being bought
Published requirement descriptionThe Trust requires the provision of an Interferon Gamma Release Assay (IGRA) testing service for the detection of Mycobacterium tuberculosis infection using the T-SPOT.TB assay, which is the Trust's established standard referred test for Tuberculosis (TB) screening and diagnosis support.
Based on current activity levels, the estimated annual demand is approximately 2,820 T-SPOT.TB tests. This volume is indicative only and does not constitute a guaranteed commitment.
The contract will ensure continuity of a reliable, high-quality referred testing service that delivers accurate and timely results to support patient diagnosis, treatment decisions and infection control requirements.
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Procedure terms & legal framework
From the official record- Procedure method
- Direct award
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 26 Oct 2026, 12:41 GMT
- Last source update
- 26 Oct 2026, 12:41 GMT
- FTS notice number
2026/S 000-100983- Latest notice
- Transparency notice (UK5)
- Delivery area
- Official registry OCID
ocds-h6vhtk-07900eFind a Tender
- Why no open competition
- Single Suppliers Technical Reasons
- Published justification
The supplier is the sole provider of the Trust's standard T-SPOT.TB testing service. Transitioning to an alternative assay would require significant clinical validation and staff training, with potential disruption to established pathways and delays to diagnosis and treatment. Maintaining the current supplier ensures continuity of service and patient care.
Notice history
2 events · 1 release on Find a Tender · since 26 Oct 2026- Transparency notice published26 Oct 2026, 12:41 GMTUK5
- Contract signature expected1 Nov 2026, 23:59 GMTscheduled
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Oxford Immunotec Ltd1 Nov 2026 – 31 Oct 2027 | £132,089 | — | Standstill |
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- OXFORD IMMUNOTEC LIMITEDAwarded supplier
Official documents & specifications (1)
Official links; attachments are not copiedNotices published for this procedure
- Transparency notice Transparency notice on Find a Tender